That it is safe with little or no side effects - I think we already know this.
It breaks new ground in terms of efficacy, it’s personalised - The evidence certainly points that way. And we know it is as personalized as it gets in a very heterogeneous disease regardless of primary tumor location.
Scaleable - I have faith on this with Flask works. This is already magnitudes greater than Provenge in its suspected efficacy and utility/required inputs. 1 leuka vs multipe to make 3 years worth of vaccines. Multiple patient specific antigens baked at just the right temp.
I suspect we will have a good day tomorrow. Someone let Bigger know.
Market Data 
Markets 
AI
